Literature DB >> 27183592

STAT3 Signaling in B Cells Is Critical for Germinal Center Maintenance and Contributes to the Pathogenesis of Murine Models of Lupus.

Chuanlin Ding1, Xingguo Chen2, Paul Dascani3, Xiaoling Hu4, Roberto Bolli5, Huang-Ge Zhang3, Kenneth R Mcleish6, Jun Yan7.   

Abstract

Ab maturation as well as memory B and plasma cell differentiation occur primarily in the germinal centers (GCs). Systemic lupus erythematosus (SLE) may develop as a result of enhanced GC activity. Previous studies have shown that the dysregulated STAT3 pathway is linked to lupus pathogenesis. However, the exact role of STAT3 in regulating SLE disease progression has not been fully understood. In this study, we demonstrated that STAT3 signaling in B cells is essential for GC formation and maintenance as well as Ab response. Increased cell apoptosis and downregulated Bcl-xL and Mcl-1 antiapoptotic gene expression were found in STAT3-deficient GC B cells. The follicular helper T cell response positively correlated with GC B cells and was significantly decreased in immunized B cell STAT3-deficient mice. STAT3 deficiency also led to the defect of plasma cell differentiation. Furthermore, STAT3 deficiency in autoreactive B cells resulted in decreased autoantibody production. Results obtained from B cell STAT3-deficient B6.MRL/lpr mice suggest that STAT3 signaling significantly contributes to SLE pathogenesis by regulation of GC reactivity, autoantibody production, and kidney pathology. Our findings provide new insights into the role of STAT3 signaling in the maintenance of GC formation and GC B cell differentiation and identify STAT3 as a novel target for treatment of SLE.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27183592      PMCID: PMC4875824          DOI: 10.4049/jimmunol.1502043

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Mcl-1 is essential for germinal center formation and B cell memory.

Authors:  Ingela Vikstrom; Sebastian Carotta; Katja Lüthje; Victor Peperzak; Philipp J Jost; Stefan Glaser; Meinrad Busslinger; Philippe Bouillet; Andreas Strasser; Stephen L Nutt; David M Tarlinton
Journal:  Science       Date:  2010-10-07       Impact factor: 47.728

Review 2.  The germinal center reaction.

Authors:  Dominique Gatto; Robert Brink
Journal:  J Allergy Clin Immunol       Date:  2010-11       Impact factor: 10.793

3.  Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization.

Authors:  Hong Xu; Jun Yan; Yiming Huang; Paula M Chilton; Chuanlin Ding; Carrie L Schanie; Li Wang; Suzanne T Ildstad
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

4.  Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells.

Authors:  Jamie L Fornek; Lorraine T Tygrett; Thomas J Waldschmidt; Valeria Poli; Robert C Rickert; Geoffrey S Kansas
Journal:  Blood       Date:  2005-10-13       Impact factor: 22.113

Review 5.  Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances.

Authors:  Desmond Yat Hin Yap; Kar Neng Lai
Journal:  J Biomed Biotechnol       Date:  2010-05-06

6.  Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus.

Authors:  Magdalene Nakou; George Bertsias; Ilias Stagakis; Michael Centola; Ioannis Tassiulas; Maria Hatziapostolou; Iraklis Kritikos; George Goulielmos; Dimitrios T Boumpas; Dimitrios Iliopoulos
Journal:  PLoS One       Date:  2010-10-14       Impact factor: 3.240

7.  Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals.

Authors:  Kenichiro Maeda; Alex Malykhin; Brittany N Teague-Weber; Xiao-Hong Sun; A Darise Farris; K Mark Coggeshall
Journal:  Blood       Date:  2009-02-17       Impact factor: 22.113

8.  Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration.

Authors:  Tatsuhiro Harada; Vasileios Kyttaris; Yansong Li; Yuang-Taung Juang; Ying Wang; George C Tsokos
Journal:  Autoimmunity       Date:  2007-02       Impact factor: 2.815

9.  Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus.

Authors:  Nicholas Simpson; Paul A Gatenby; Anastasia Wilson; Shreya Malik; David A Fulcher; Stuart G Tangye; Harinder Manku; Timothy J Vyse; Giovanna Roncador; Gavin A Huttley; Christopher C Goodnow; Carola G Vinuesa; Matthew C Cook
Journal:  Arthritis Rheum       Date:  2010-01

10.  B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans.

Authors:  Danielle T Avery; Elissa K Deenick; Cindy S Ma; Santi Suryani; Nicholas Simpson; Gary Y Chew; Tyani D Chan; Umamainthan Palendira; Jacinta Bustamante; Stéphanie Boisson-Dupuis; Sharon Choo; Karl E Bleasel; Jane Peake; Cecile King; Martyn A French; Dan Engelhard; Sami Al-Hajjar; Saleh Al-Muhsen; Klaus Magdorf; Joachim Roesler; Peter D Arkwright; Pravin Hissaria; D Sean Riminton; Melanie Wong; Robert Brink; David A Fulcher; Jean-Laurent Casanova; Matthew C Cook; Stuart G Tangye
Journal:  J Exp Med       Date:  2010-01-04       Impact factor: 14.307

View more
  27 in total

Review 1.  Novel Treatments in Lupus.

Authors:  Vasileios C Kyttaris
Journal:  Curr Rheumatol Rep       Date:  2017-03       Impact factor: 4.592

2.  Serine/threonine phosphatase PP2A is essential for optimal B cell function.

Authors:  Esra Meidan; Hao Li; Wenliang Pan; Michihito Kono; Shuilian Yu; Vasileios C Kyttaris; Christina Ioannidis; Noe Rodriguez Rodriguez; Jose C Crispin; Sokratis A Apostolidis; Pui Lee; John Manis; Amir Sharabi; Maria G Tsokos; George C Tsokos
Journal:  JCI Insight       Date:  2020-03-12

3.  TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B-T cell axis and decreases tumour burden in murine fibrosarcoma.

Authors:  Kavitha Premkumar; Bhavani S Shankar
Journal:  Cancer Immunol Immunother       Date:  2020-07-13       Impact factor: 6.968

4.  Tumor Microenvironment following Gemcitabine Treatment Favors Differentiation of Immunosuppressive Ly6Chigh Myeloid Cells.

Authors:  Caijun Wu; Xiaobin Tan; Xiaoling Hu; Mingqian Zhou; Jun Yan; Chuanlin Ding
Journal:  J Immunol       Date:  2019-11-27       Impact factor: 5.422

5.  PKK deficiency in B cells prevents lupus development in Sle lupus mice.

Authors:  D Oleksyn; J Zhao; A Vosoughi; J C Zhao; R Misra; A P Pentland; D Ryan; J Anolik; C Ritchlin; J Looney; A P Anandarajah; G Schwartz; L M Calvi; M Georger; C Mohan; I Sanz; L Chen
Journal:  Immunol Lett       Date:  2017-03-06       Impact factor: 3.685

Review 6.  Gammaherpesviruses and B Cells: A Relationship That Lasts a Lifetime.

Authors:  Kaitlin E Johnson; Vera L Tarakanova
Journal:  Viral Immunol       Date:  2020-01-08       Impact factor: 2.257

7.  STAT3-mediated allelic imbalance of novel genetic variant Rs1047643 and B-cell-specific super-enhancer in association with systemic lupus erythematosus.

Authors:  Yanfeng Zhang; Kenneth Day; Devin M Absher
Journal:  Elife       Date:  2022-02-21       Impact factor: 8.140

Review 8.  Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease.

Authors:  Nina Couette; Wael Jarjour; Jonathan E Brammer; Alexa Simon Meara
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

9.  Combinatory treatment using tacrolimus and a STAT3 inhibitor regulate Treg cells and plasma cells.

Authors:  Jin-Sil Park; Sung-Min Kim; Sun-Hee Hwang; Si-Young Choi; Ji Ye Kwon; Seung-Ki Kwok; Mi-La Cho; Sung-Hwan Park
Journal:  Int J Immunopathol Pharmacol       Date:  2018 Jan-Dec       Impact factor: 3.219

Review 10.  Signal Transducer and Activator of Transcription 3 Control of Human T and B Cell Responses.

Authors:  Elissa K Deenick; Simon J Pelham; Alisa Kane; Cindy S Ma
Journal:  Front Immunol       Date:  2018-02-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.